Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 5.33
-0.19 (-3.35%)
Sep 11, 2026, 4:08 PM HKT
Ocumension Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Ocumension Therapeutics stock has a consensus rating of "Buy" and an average price target of $9.17. The average 1-year stock price forecast is 72.05% higher than the current stock price, while the lowest is $7.94 (+48.97%) and the highest is $10.41 (+95.31%).
Price Target: $9.17 (+72.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ocumension Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains $8.81 → $7.92 | Hold | Maintains | $8.81 → $7.92 | +48.59% | Sep 2, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.16 | Buy | Maintains | $10.16 | +90.62% | Apr 3, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 804.35M
Increased by 32.52%
Revenue Next Year
1.39B
from 1.07B
Increased by 30.74%
EPS This Year
0.07
from -0.11
EPS Next Year
0.25
from 0.07
Increased by 257.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.